Logo image
Using DNA methylation and genetic variation to investigate genetic burden
Dissertation   Open access

Using DNA methylation and genetic variation to investigate genetic burden

Chloe Barbara Moel
University of Iowa
Doctor of Philosophy (PhD), University of Iowa
Spring 2026
DOI: 10.25820/etd.008350
pdf
Moel_Thesis_Final1.92 MBDownloadView
Open Access

Abstract

Measuring gene burden, a calculation that combines gene variability into a single, gene- level score, is one way to investigate causes of genetic diseases that may not be caused by one variant alone. DNA methylation of CpG sites, a known regulator of disease, has great influence on gene expression but is not accounted for in traditional gene burden analyses (GBA), highlighting a gap in our ability to identify disease causing genes. We propose the first GBA that includes genetic information alongside DNA methylation. To combine DNA methylation and genetic variation, we created two scores – Burden Estimate from Weighted Integration of Site- specific Epigenetic Changes (BeWISE) and Burden Estimate from Modified and Associated Genetic Change (BeMAGIC). These two scores combined create the MagicWise Index: a Phred- scaled score of predicted deleteriousness. To prioritize causal variation in our scores, we created novel weighting and filtering schemes at both the nucleotide and gene level. After filtering, our MagicWise index encompassed ~15,000 genes and contained ~180,000 CpG sites. Applied to several different datasets, the MagicWise Index identified known causes of genetic diseases, as well as highlighted possible novel causes of genetic disease. The MagicWise Index identifies and prioritizes biologically significant genes and has wide utility for many different genetic diseases, and aims to aid in the holistic, comprehensive analysis of genetic diseases.
Bioinformatics Epigenetics Genetics Genomics Computational genetics Computational genomics

Details

Metrics

1 Record Views
Logo image